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Intrarenal localization of angiotensin II type 1 receptor mRNA
in the rat
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Intrarenal localization of angiotensin II type 1 receptor mRNA in the
rat. We examined intrarenal localization of angiotensin II type 1
receptor (AT!) mRNA in kidneys of normal adult male Munich Wistar
rats using the methods of reverse transcription-polymerase chain reac-
tion (RT-PCR) and in situ hybridization. For RT-PCR, we used a rat
AT! subtype A (AT1A)-specific oligonucleotide primer pair. To semi-
quantitatively assess the expression level of AT! mRNA among several
regions of kidney, ATI cDNA was coamplified with /3-actin cDNA.
When compared to the level in the adrenal gland (expressed as 100%),
the level of ATI mRNA was markedly higher in glomeruli (273 69%),
followed in intensity by the renal papilla (151 57%), renal cortex (139
19%), and renal medulla (114 35%). In situ hybridization studies,
using a 479 bp nucleotide fragment from ATIA-coding exon as a probe,
also revealed a glomerular preponderant pattern of AT! mRNA local-
ization. Thus, within the glomerulus, ATI mRNA localized in mesan-
gial areas, predominantly at the vascular pole. In the vascular compo-
nents of the juxtaglomerular apparatus (JGA), namely the terminal
portion of the afferent arteriole (that is, immunohistochemically renin-
positive site) and extraglomerular mesangial cells, the latter showed
AT1 mRNA localization in the non-manipulated kidney, while AT1
mRNA was undetectable in the arteriole outside the JGA. The kidneys
of rats treated with an angiotensin I converting enzyme inhibitor
(ACEI) showed extension of the AT1 mRNA localization on the
afferent arteriole toward the interlobular artery. We speculate that the
observed pattern of AT1 mRNA localizing in the glomerular vascular
pole and JGA may account for the unique physiological and pathophys-
iological actions of angiotensin II (Ang II), that is: (I) the renal
hemodynamic effect of Ang II involves simultaneous increases in
afferent and efferent arteriolar resistances and a reduction in ultrafiltra-
tion coefficient; (2) experimental glomerular sclerosis, sensitive to
pharmacological inhibition of angiotensin II, is commonly prominent at
the vascular pole; and (3) a negative feedback relationship exists
between angiotensin II and renin, presumably via the AT! on the JGA.
With the introduction of novel nonpeptide angiotensin II
(Ang II) receptor (Ang IIR) antagonists [1, 2], several types of
Ang hR have been identified. These subtypes of Ang hR show
organ specific distribution [3, 4] with correlation between
specific types and function in some organs [11. Ang HR is highly
expressed in the kidney, adrenal gland, brain, liver and vascu-
lature [2, 3], and Ang II has varying effects via its interactions
with specific Ang hR. Ang II maintains circulatory homeostasis
[5, 6], acts as a neurotransmitter in the central nervous system
[7] and stimulates hypertrophy and proliferation of cells [8—15].
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The cloning of Ang hR type 1 eDNA (AT1) [16, 17] has allowed
further study of this receptor's distribution. Subtypes of ATI
have been identified in the rat (IA and 1B) [181, but not in
humans.
Although Ang hR has already been recognized in mesangial
and vascular smooth muscle cells, the localization of the
specific AT1 mRNA in kidney has not been fully elucidated. In
this study, the expression pattern of ATL mRNA was analyzed
by reverse transcription-polymerase chain reaction (RT-PCR)
and in situ hybridization.
Methods
Animals
Male adult Munich Wistar rats (total N = 12), body weight
250 to 300 g, were studied. In situ hybridization studies were
performed in rats receiving a normal rat chow diet and tap water
ad libitum, and in rats treated with enalapril maleate, 200 mgIl
drinking water (Merck Sharp and Dohme Research Lab., Rah-
way, New Jersey, USA) for two weeks (N 6). Rats were
anesthetized with sodium pentobarbital (Abbott Lab., South
Chicago, Illinois, USA) for tissue harvesting for RT-PCR or in
situ hybridization.
Glomerular isolation for RT-PCR and mesangial culture for
in situ hybridization
Kidneys were removed under anesthesia, and renal cortex
was dissected free from the remainder of the kidney, cut into
small pieces and then passed through serial sieves to isolate
glomeruli. The glomerular preparations had less than 5% tubu-
lar contamination [19]. Primary cultures of mesangial cells were
obtained from outgrowths of isolated rat renal glomeruli as
described [20]. Briefly, the glomeruli were cultured in medium
which consisted of RPM! with glutamine supplemented with
16% FBS, penicillin, streptomycin and amphotericin B. After
mesangial cells had reached confluence they were subeultured,
and after three subcultures they were used for study. They
represented an apparently uniform cell population as evaluated
by the following criteria, that is: (a) morphology, (b) histochem-
ically positive for actomyosin with fibrillar appearance, but (c)
not staining for factor VIII.
Reverse transcriprion-polymerase chain reaction (R T-PCR)
To compare relative amounts of AT1 mRNA in different
regions of the kidney, we extracted RNA from glomeruli
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isolated by differential sieving (see above), papilla, renal cortex,
renal medulla and adrenal gland. Total RNA from tissues from
three rats (six kidneys) was extracted and pooled from each part
as previously described [21]. It was further purified with 4 M
LiCl and finally resuspended in DEPC-treated water. Three
micrograms total RNA were reverse-transcribed to first strand
cDNA by 100 U Moloney murine leukemia virus (Mo-MLV)
transcriptase (BRL, Gaithersburg, Missouri, USA) with 50 ng
random hexamer, 10 mri DTT, 2 mrvi dNTP in buffer containing
50 mM Tris-HCI, 75 msi KC1 and 3 m MgCI2 at 37°C for 60
minutes, followed by RNase digestion [22]. PCR was performed
by coamplification with two different primers [23—25], one for
rat AT1A and another for rat /3-actin. AT1 gene, primer 1
(antisense) was 5'-GGGAGCGTCGAATTCCGAGACTCAT-
AATGA-3', and primer 2 (sense) was 5'-ACCCTCTACAG-
CATCATCTTTGTGGTGGGGA-3'. Thus, the cDNA amplifi-
cation product was predicted to be 479 bp in length. RT-PCR
with rat cytoplasmic /3-actin served as an invariant control. The
primers for /3-actin [26] were defined by the following genomic
base sequence: primer 1' (antisense), 5'-ACCTTCAACAC-
CCCAGCCATGTACG-3'; primer 2' (sense), 5'-CTGATCCA-
CATCTGCTGGAAGGTGG-3'. f3-actin primers spanned two
introns and resulted in a 703 bp eDNA amplification product.
All the primers were checked for absence of fortuitous homol-
ogy to any sequence listed in a gene sequence data bank
(IntelliGenetics, Inc., Mountain View, California, USA). After
preparation of the first strand eDNA, one-tenth of the reaction
solution was mixed with PCR reagents. After all the PCR
reactions, 100 d contained the following components: 2.5 U
Taq polymerase (Promega, Madison, Wisconsin, USA), 20
pmoles each of AT1A primers, 6 pmoles each of 13-actin
primers, 0.2 mrt dNTP, 10 mrvi Tris-HC1, 50 mivi KCI, 3 mM
MgCl2 [22, 27]. Reaction tubes were overlaid with 70 jd of
mineral oil to prevent evaporation. PCR was performed in a
programmable thermal controller (MJ Research, Inc., Water-
town, Massachusetts, USA) which was programmed as follows:
incubation at 92°C for five minutes (initial melt), followed by 25
cycles, 92°C for one minute (denature), 65°C for 40 seconds
(anneal) and 72°C for 1.5 minutes (extend). PCR was completed
by a final extension at 72°C for 10 minutes. For analysis of the
PCR products, each half of the reaction solution was extracted
by chloroform, dried and size-fractionated on 1.5% agarose
gels, and stained with ethidium bromide. For Southern blot
analysis of PCR products, gels were denatured, transferred, and
blotted onto Zeta-bind nylon membranes. To test for specific
PCR amplification products, fragments of 359 bp AT1 and 703
bp /3-actin were used for hybridization probe. The sequence of
the probe was located in the middle of the amplified fragment
and did not include the region of primers. Areas of both AT1
and f3-actin bands coamplified from each sample were measured
by densitometry and the ratio of AT! to /3-actin calculated.
RT-PCR was performed four times on RNA from each region of
the kidney, then results were averaged. Results are given as
mean 1 SE.
Prehybridization
To prevent RNA degradation, all reagents and solutions were
treated by 0.1% diethylpyrocarbonate, DEPC (Fluka,
Ronkonkoma, New York, USA). All procedures, unless other-
anesthesia, rats were perfused in vivo via the left ventricle with
20 ml PBS followed by 20 ml of 4% paraformaldehyde [28].
Tissues were harvested from six rats (3 normal and 3 ACE!
treated) and placed overnight in 4% paraformaldehyde at 4°C,
processed routinely, embedded in paraffin, and stored at 4°C
until beginning of hybridization studies. Five micrometer sec-
tions were then cut and placed on polylysine (Sigma, St. Louis,
Missouri, USA) treated glass slides and prepared in a concen-
tration of 50 g/ml in 10 mrt Tris-HC1, pH 8.0 [29]. Slides, on
which paraffin-embedded sections were placed, were dewaxed
in xylene, then hydrated serially in 100% to 30% ethanol. Slides
were refixed in 4% paraformaldehyde for 20 minutes, PBS
washed, and then treated with 20 g/ml proteinase K in 50 mrvi
Tris-HC1, pH 7.4 and 5 mM EDTA for eight minutes [28].
Subsequently, slides were treated with 0.1 M triethanolamine
for 10 minutes, followed by addition of 0.4% (vol/vol) acetic
anhydride for 10 minutes. After rinsing in PBS, slides were
successively dehydrated in 30% to 100% ethanol,
Hybridization and posthybridization
5 x l0 cpm/slide of 35S-labeled cRNA for AT! and control
35S-labeled probes (see below) were used. Approximate volume
per slide of hybridization mixture was 50 j.d. Hybridization
buffer contained 50% deionized formamide, 10% dextran sul-
fate, 8 mi't DTT, 0.2 mg/mI tRNA and 1 x salts (300 mM NaCl,
10 mM Tris-HC1, 5 ms'i EDTA, 0.02% polyvinylpyrolidone,
0.02% Ficoll and 0.02% BSA). Slides were incubated overnight
at 50°C in a sealed humidified container, into which 1 x salts
and 50% formamide were placed to maintain moisture. Subse-
quently, slides were washed in 50% formamide, 2 x SSC (300
mM NaCI, 30 m sodium citrate, pH 7.0), 20 m DTT at 50°C
for 60 minutes, followed by TEN buffer (10 mivi Tris-HC1, pH
7.6, 5 msi EDTA, and 500 m NaC1) at 37°C, and then treated
with 50 g/ml RNase at 37°C for 30 minutes [30]. Slides were
washed in 2 x SSC, followed by 0.1 x SSC at 50°C, dehydrated
in 30% to 100% ethanol with 0.3 M ammonium acetate, and
air-dried. They were dipped into photographic emulsion (Poly-
sciences Inc., Warrington, Pennsylvania, USA), diluted 1:1 in
2% glycerol solution, left on ice for 15 minutes, dried overnight
in a dark box, and exposed at 4°C for seven weeks [31]. The
slides were developed with D-19 developer and counterstained
with 0.05% toluidine blue.
Probe for in situ hybridization
We used a 472 bp fragment from cDNA of rat angiotensin II
receptor type lA (AT1A), vascular type [32]. This fragment has
the least homology with the rat Ang fIR subtype lB (AT1B)
gene. The fragment was obtained after double-digestion by
EcoR I and Sac I from whole cDNA of rat AT1A and was
located within the exon of the protein coding region. This 472
bp-length DNA was then inserted into PGEM4Z vector
(Promega) for in vitro synthesis of cRNA. After linearization of
the plasmid containing AT1A by pertinent restriction enzymes,
we transcribed sense and antisense cRNA of AT1A using RNA
polymerases with labeled 35S-UTP (Du Pont, Boston, Massa-
chusetts, USA) in the reaction mixture. Sense cRNA was used
wise specified, were performed at room temperature. After as a negative control.
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Fig. 1. A. Coamplfication of AT! (479 bp) with f3-actin (703 bp) for semi-quantitative analysis of ATI mRNA expression in renal glomeruli,
papilla, cortex, medulla and adrenal gland. Glomeruli showed the most intense band for AT1 mRNA. B. Varied degrees of AT! expression in
different regions of the kidney. Following Southern analysis, the relative ratio of expression of AT! mRNA to /3-actin mRNA was measured by
densitometry. AT! was expressed most abundantly in glomeruli (P < 0.05 vs. adrenal gland), Data are shown as mean 1 SE.
Immunohistochemistry
Five micrometer sections of paraffin-embedded tissues were
stained by an indirect immunoperoxidase technique (avidin-
biotin-peroxidase complex method) [33]. After removal of par-
affin by xylene, the tissue sections were incubated with 0.3%
hydrogen peroxide for 30 minutes to inactivate endogenous
peroxidase and to decrease background. Washing in PBS was
followed by covering slides with goat serum (Sigma). Immuno-
reaction was done by primary rabbit anti-rat renin antibody at
dilution 1:1000 in PBS, 1% BSA, and 0.1% sodium azide at
room temperature overnight [34]. After PBS washing, slides
were incubated with goat biotinylated anti-rabbit antibody
(Sigma) at 1:30 dilution in 50 ms'i Tris-HC1, pH 7.6. Then slides
were incubated with avidin conjugated with hydrogen peroxide
at room temperature for 30 minutes, followed in sequence by
PBS washing and addition of 3,3'-diaminobenzidine (Sigma) as
a chromogenic substrate. Counterstaining was done with tolu-
idine blue or Meyer's hematoxylin.
Results
Semi-quantitative RT-PCR of ATI mRNA
RT-PCR was performed to study relative amount of AT1
mRNA using total RNA derived from adrenal gland, isolated
glomeruli, papilla, renal cortex and renal medulla. Coamplifi-
cation of /3-actin and AT! was performed in the exponential
phase to avoid the "tube effect" of PCR [351. As illustrated in
Figure 1A, ATI mRNA expression was most prominent in
glomeruli among the regions of the kidney studied. After
assessment by densitometry, amounts of amplified AT1 PCR
product were normalized by /3-actin product to evaluate the
relative amount of AT1 mRNA (Fig. 1B), and expressed as a
relative ratio to the adrenal gland, set as 100%. Glomeruli
showed the highest level of mRNA (273 69%, P < 0.05 vs.
adrenal gland) with lesser amounts, in decreasing order, in
papilla (151 57%), renal cortex (139 19%), renal medulla
(114 35%) and adrenal gland (100%). Controls performed
without reverse transcriptase, using procedures identical to
those for RT-PCR, verified the absence of contamination by
genomic DNA.
Localization of AT! in kidney
In situ hybridization with AT1A antisense cRNA was per-
formed to localize the mRNA of this receptor. Within the
kidney, the signal localized primarily to the glomeruli (Fig. 2,
bright field). Proximal tubules, but not distal, showed occa-
sional weak but not definite mRNA signal (Fig. 2, dark field).
Within glomeruli, the signal localized especially in mesangial
areas. The density of the signal was more intense toward the
vascular pole. Glomerular epithelial and endothelial cells
showed no appreciable signal.
Interlobular arteries and large vessels did not show the signal.
Sections of arterioles distant from the vascular pole also did not
express AT! mRNA. However, the vascular component of the
juxtaglomerular apparatus (JGA), namely the extraglomerular
mesangial cells (Fig. 3), located between the afferent and
efferent arterioles, distinctively expressed AT!, whereas vas-
cular smooth muscle cells of the terminal afferent arteriole
showed only very weak signal in the normal rats. The macula
densa area did not show any message for AT! mRNA.
After manipulation of renin-angiotensin system (RAS) by oral
administration of enalapril for two weeks, the expression of the
AT! gene was extended more along the afferent arteriole, and
the signal was stronger in the early portion of the efferent
arteriole (Fig. 4, bright and dark field). The specificity of
hybridization was supported by the findings in the adrenal
gland. In the adrenal gland, the signal was distributed densely
within the cortex, forming a stripe, with less signal in the
medulla (data not shown).
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In vitro, in situ hybridization of cultured rat mesangial cells
The localization of AT! mRNA was verified in cultured rat
mesangial cells. After the third passage from primary culture,
mesangial cells showed distinctive expression of AT1 mRNA
distributed around the nuclei, as shown in Figure 5.
Immunohistochemistry of renin in juxtaglomerular apparatus
To verify whether the regions of renin production are corre-
lated with the localization of AT!, we performed immunohisto-
chemical staining on adjacent serial sections of the tissues
which were used for in situ hybridization. In the normal rat, as
many previous studies have shown, renin positive cells showed
restrictive localization in the terminal afferent arteriole at the
vascular pole, and renin was rarely detected in the efferent
arteriole. As shown in Figure 6, after enalapril treatment, renin
positive cells extended toward the interlobular artery from the
glomerular end of the afferent arteriole (one component of
JGA), and were rarely detected in efferent arteriole and extra-
glomerular mesangial cells. Comparison between Figures 4 and
6 illustrates renin-positive cells with AT! mRNA in the terminal
end of the afferent arteriole, although AT1 mRNA positive
extraglomerular mesangial cells stained only weakly for renin.
Discussion
This study demonstrates localization of AT! mRNA in the
adult rat kidney by RT-PCR and in situ hybridization. To
evaluate the message of ATI semi-quantitatively, we performed
RT-PCR using total RNA from several regions of the kidney.
The RT-PCR method is a powerful tool to analyze small
amounts of mRNA. However, the varied yield of amplification
[35], the so-called "tube effect," necessitates coamplification of
AT1 with a relatively invariant mRNA, such as /3-actin or with
an internal standard for semi-quantitative comparisons, as
recommended [271.
Further, such a coamplification must be done in the exponen-
tial phase, and contamination of genomic DNA in samples must
be ruled out. With these caveats, this semi-quantitative tech-
nique allows comparison of relative amounts of mRNA.
Previously, high homology between the two subtypes of AT1
(1A and lB) was identified. However, the distribution of these
subtypes varied in different organs. Of special interest, a
dominant gene expression of the lA type was seen in the adult
kidney [121. Therefore, we used a terminal end of the AT1A
protein coding region as a probe, which was less homologous to
ATIB. The specificity of this probe was evaluated by compar-
ing the results of RT-PCR to those of in situ hybridization.
Thus, our RT-PCR study, using a specific primer pair for AT1A,
revealed the greatest amount of AT1A mRNA in glomeruli.
This was paralleled by the findings of our in situ hybridization
study, confirming the specificity of the probe for AT1A.
Our in situ hybridization study showed AT! mRNA localized
specifically within the kidney and the adrenal cortex [36, 371.
Ang II has actions on both sodium and bicarbonate reabsorp-
tion in proximal tubules [38, 391, indicating the presence of
tubular Ang II receptor, as suggested by previous studies of the
site of Ang II in proximal tubules [40—421. However, in our
study, the very weak AT1 signal detected in proximal tubules,
due to the limited resolution of the in situ hybridization tech-
nique itself to distinguish real signal from background, could
not be definitively interpreted.
Glomeruli showed the greatest amount of AT1 mRNA ex-
pression in the mesangial area. Further, by in vitro in situ
hybridization, cultured mesangial cells expressed AT1 mRNA.
Thus, these in vivo and in vitro studies demonstrate that
mesangial cells are potential effecter sites for Ang II in physi-
ological and pathophysiological settings.
In addition, this study investigated the potential relationship
of AT1 and the JGA. The JGA is composed of myoepithelial
cells (also called granular cells) and extraglomerular mesangial
cells. The latter are identified on the basis of their anatomical
localization [43, 441. The existence of an intrinsic renin angio-
tensin system in the JGA has been suggested by several
immunohistochemical studies showing co-localization of renin
and Ang II [34, 45, 46]. Our data show that extraglomerular
mesangial cells actually expressed more abundant AT! mRNA
than the granular cells in normal rats. Immunostaining in
normal rats on adjacent sections for renin showed positive cells
in only the part of the afferent arterioles immediately adjacent
to the glomerular vascular poles.
Renin production by the JGA is regulated by several factors.
Of note, Ang H has negative feedback on renin gene expression.
Conversely, inhibition of Ang II by ACEI has been reported to
enhance the expression of renin mRNA [47, 48]. This up-
regulation of renin was accompanied by a change in the pattern
of renin-positive cells, with recruitment of renin gene expres-
sion from JGA to the proximal afferent arteriole.
When RAS was manipulated by ACE! [49, 501, we found that
AT! expression was expanded in close association with en-
hanced renin expression. Thus, the extension of the AT1
mRNA positive region along the afferent arteriole toward the
interlobular artery, as well as definite expression of AT! in the
efferent arteriole, was seen in association with extension of
renin positive cells to these areas (Fig. 6). RT-PCR (data not
shown) revealed that ACEI manipulation enhanced the AT!
expression level numerically (but not statistically) at the whole
kidney level, as other investigators have suggested [32]. The
Fig. 2. Distribution pattern of AT] mRNA in cortex of the normal adult rat kidney. AT! was expressed mainly in mesangial area. The intensity
of the message was higher at the vascu!ar pole (bright and dark field, x 145).
Fig. 3. AT] mRNA in normal adult rats expressed predominantly in extraglomerular mesangial cells, defined anatomically to be localized between
the afferent and the efferent arteriole. However, in both of the arterioles at the vascular pole, ATI message was undetectable (bright field, x293).
Fig. 4. AT] mRNA expression in rats treated with ACE! extended along the afferent arteriole (arrow) from the glomerular vascular pole. AT1 also
was expressed in the efferent arteriole (bright and dark field, x293).
Fig. 5. AT] rnRNA expressed in cultured rat mesangial cells (X293).
Fig. 6. Study of the JGA by immuno/zistochemical staining for renin, showing renin-positive cells at the afferent arteriole at the glomerular
vascular pole. Manipulation of RAS by ACE! treatment, induced extension of renin-positive cells (arrow) from the vascular pole to the interlobular
artery (x122).
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enhanced AT! mRNA expression in the afferent arterioles
shown by our in situ hybridization study represents only a
fraction of the mRNA of the whole kidney; therefore, such a
selective change did not result in marked differences by RT-
PCR. The similar pattern of AT! and renin expression suggests
that renin producing JGA cells express AT! and, further, that
AT! on JGA may be involved in the negative feedback regula-
tion, which is known to exist between Ang 11 and the renin
level.
In addition to JGA cells, ATI was expressed on mesangial
cells and extraglomerular mesangial cells. These patterns of
localization are reminiscent of the functions of Ang II, that is,
glomerular sclerosis and mesangial matrix accumulation sensi-
tive to Ang II are more prominent in the vascular pole, Ang II
results in increased afferent (RA) and efferent artenolar (RE)
resistances, and Ang II decreases ultrafiltration coefficient (Kr).
It was previously postulated that these simultaneous constric-
tive responses in RA, RE, and Kf represent contraction of both
intra- and extraglomerular mesangial cells, which juxtapose the
glomerular capillary network and arterioles at the vascular pole.
This anatomical arrangement of mesangial cells together with
AT1 receptor localization on them, may provide a highly
efficient measure to induce concurrent narrowing of the arteri-
oles and reduction in filtering surface area. Further, the pres-
ence of AT1 receptor on JGA and modulation of its expression
in parallel with renin supports local regulation of the RAS.
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